The Multidisciplinary Association for Psychedelic Studies (MAPS) is recruiting up to 150 participants for a phase 3 clinical trial investigating methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for the treatment of posttraumatic stress disorder (PTSD).
- The official news site of
Psych Congress - October 3-6, 2019
- San Diego, CA
Articles
December 06, 2018
As many as one-quarter of suicide attempts are associated with psychotic experiences, according to a systematic review and meta-analysis published online in JAMA Psychiatry.
December 04, 2018
More frequent in-person social interaction is linked with a significantly lower risk of symptoms of major depression and posttraumatic stress disorder (PTSD) in US military veterans, according to a study published online.
November 29, 2018
An investigational schizophrenia treatment demonstrated a superior weight gain profile, compared with olanzapine, in a phase 3 trial, Alkermes officials announced.
November 28, 2018
Childhood trauma of all types appears to have a causal link with psychotic experiences in early adulthood, according to a study published online in JAMA Psychiatry.